Allgenesis Biotherapeutics Inc.

Quick facts

Phase 2 pipeline

• AG-73305 · Oncology
  AG-73305 is a small molecule inhibitor of the PI3K/AKT/mTOR pathway.

Phase 1 pipeline

• AG-80308

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Allgenesis Biotherapeutics Inc. portfolio CI brief
• Allgenesis Biotherapeutics Inc. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies